Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
3.470
Zitationen
8
Autoren
2006
Jahr
Abstract
Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events. Treatment improved visual acuity on average at 1 year. (ClinicalTrials.gov number, NCT00061594 [ClinicalTrials.gov].).
Ähnliche Arbeiten
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
1993 · 24.582 Zit.
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 · 16.333 Zit.
The biology of VEGF and its receptors
2003 · 9.504 Zit.
The number of people with glaucoma worldwide in 2010 and 2020
2006 · 7.311 Zit.
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.206 Zit.